Lumida
/VRCA
⌘K
Verrica Pharmaceuticals Inc

Verrica Pharmaceuticals Inc

VRCA
$4.91USD-0.81%-0.04 today

MARKET CAP

84.3M

P/E (TTM)

FWD P/E

DAY RANGE

$5 – $5

52W RANGE

$3
$10
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$12.0M$9.0M$5.1M$7.6M$35.6M
YoY %-24.7%-43.3%+47.7%+370.2%
P / Sales20.6x10.9x60.3x4.8x2.5x
EV / Sales23.3x7.6x58.8x7.1x2.3x
Gross Profit, Adj.$12.0M$9.0M$4.4M$4.8M$32.1M
YoY %-24.7%-51.5%+10.2%+565.9%
Margin %100.0%100.0%85.4%63.8%90.3%
EV / Gross Profit23.3x7.6x68.8x11.2x2.5x
EBITDA, Adj.$-30.4M$-20.6M$-62.7M$-65.5M$-11.8M
YoY %+23.8%+32.4%-204.6%-4.5%+82.0%
Margin %-253.6%-227.8%-1223.1%-865.6%-33.2%
EV / EBITDA-9.2x-3.3x-4.8x-0.8x-6.8x
EBIT$-30.9M$-21.3M$-63.2M$-65.8M$-11.9M
YoY %+23.1%+31.1%-196.9%-4.1%+81.9%
Margin %-257.6%-235.8%-1233.8%-870.2%-33.6%
EV / EBIT-9.0x-3.2x-4.8x-0.8x-6.8x
Net Income$-35.1M$-24.5M$-67.0M$-76.6M$-17.9M
YoY %+17.8%+30.2%-173.6%-14.3%+76.6%
Net Margin-292.3%-271.1%-1307.5%-1012.1%-50.3%
EPS (GAAP)-$13.00-$7.20-$14.80-$14.78-$1.68
YoY %+24.0%+44.6%-105.6%+0.1%+88.6%